Bob Dudley, BP CEO, discusses how geopolitics and sanctions on Russia impact business, with Mad Money host Jim Cramer.» Read More
Jim Cramer explains what to watch ahead of the open, including 3D Systems and Micron.
After earnings Panera marched higher while Buffalo Wild Wings tanked by 15 percent. That doesn’t seem right.
Mad Money host Jim Cramer dissects how Wall Street digested earnings reports by Buffalo Wild Wings and Panera Bread.
Jim Cramer can’t help but wonder if this old dog of a stock has learned new tricks.
Tom Quinlan, R.R. Donnelley & Sons Company president and CEO, discusses free cash flow and its technology that helps customers know what happens to its products during shipping.
Mad Money host Jim Cramer outlines warring factions in the market and why they can't come to an agreement.
Are you finding it next to impossible to anticipate this market? There’s a reason. In fact, Cramer says there are five of them.
The Fast Money traders share their final trades of the day.
Mobileye is set to go public next week. CNBC's Phil LeBeau provides insight into the software maker for driverless cars.
The Fast Money traders take a look at today's biggest market movers.
With the dollar hitting 10-month highs today, Paul Hickey, Bespoke Investment Group, says to focus on companies with domestic exposure.
Behrooz Abdi, InvenSense CEO and president, discusses a strong growth forecast for the year and expresses excitement about market share gains. But he doesn't talk about the company's relationship with Apple.
CNBC's Bertha Coombs reports Carl Icahn now holds just a 3.61 percent stake in Family Dollar.
The FM traders break down trades on Weight Watchers and Shutterfly following their earnings reports.
CNBC's Kate Kelly reports the S&P has declared Argentina is in the state of selective default. The Argentina Economy Prime Minister is expected to speak.
Neil Doshi, CRT Capital, analyzes Q2 earnings by Yelp.
Dissecting quarterly numbers by social stocks, with the Fast Money traders.
Marc Harris, RBC Capital Markets Head of Global Research, discusses his investment strategy and provides his top three stock picks for the second half.
One company reported a strong quarter and the other flopped—but CNBC's Jim Cramer thinks both stocks are a buy.
CNBC's Jim Cramer on Wednesday identified two biotechnology stocks that he thinks could climb.